| Identification | Back Directory | [Name]
1H-Indole-2-carboxamide, 7-chloro-N-[(1S)-2-[[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]amino]-1-(cyclopropylmethyl)-2-oxoethyl]- | [CAS]
2713437-86-4 | [Synonyms]
Pomotrelvir
7-Chloro-N-((S)-1-(((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)amino)-3-cyclopropyl-1-oxopropan-2-yl)-1H-indole-2-carboxamide
1H-Indole-2-carboxamide, 7-chloro-N-[(1S)-2-[[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]amino]-1-(cyclopropylmethyl)-2-oxoethyl]- | [Molecular Formula]
C23H26ClN5O3 | [MOL File]
2713437-86-4.mol | [Molecular Weight]
455.94 |
| Chemical Properties | Back Directory | [Boiling point ]
880.8±65.0 °C(Predicted) | [density ]
1.336±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
12.06±0.46(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activity and can be used in the research of novel coronavirus (COVID-19)[1]. | [References]
[1] Jessica R.?Spengler, et al. Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA – March 21–25, 2022. |
|
|